(RTTNews) - Crinetics Pharmaceuticals Inc (CRNX) reported Loss for its third quarter that increased from the same period last year and missed the Street estimates.
The company's earnings came in at -$130.09 million, or -$1.38 per share. This compares with -$76.83 million, or -$0.96 per share, last year.
Analysts on average had expected the company to earn -$1.25 per share. Analysts' estimates typically exclude special items.
Crinetics Pharmaceuticals Inc earnings at a glance (GAAP) :
-Earnings: -$130.09 Mln. vs. -$76.83 Mln. last year. -EPS: -$1.38 vs. -$0.96 last year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Crinetics Pharmaceuticals Inc Q3 Loss Increases, Misses Estimates
Published 1 day ago
Nov 6, 2025 at 10:05 PM
Negative
Auto